Executive Vice President and Chief Financial Officer
Gilead Sciences, Inc.
Robin L. Washington is Senior Vice President and Chief Financial Officer for Gilead Sciences, Inc., one of the largest biopharmaceutical companies in the world, with a rapidly expanding
product portfolio and a growing pipeline of investigational drugs. In this role, Washington oversees the Global Finance and Information Technology organizations. Washington joined Gilead in 2008 as Senior Vice President and Chief Financial Officer. Washington was previously Chief Financial Officer of Hyperion Solutions, which was acquired by Oracle Corporation in March 2007. Prior to that, Washington served in a number of executive positions with PeopleSoft, most recently in the role of Senior Vice President and Corporate Controller.
product portfolio and a growing pipeline of investigational drugs. In this role, Washington oversees the Global Finance and Information Technology organizations. Washington joined Gilead in 2008 as Senior Vice President and Chief Financial Officer. Washington was previously Chief Financial Officer of Hyperion Solutions, which was acquired by Oracle Corporation in March 2007. Prior to that, Washington served in a number of executive positions with PeopleSoft, most recently in the role of Senior Vice President and Corporate Controller.
Washington previously served on the Board of Directors of Tektronix, Inc. (acquired by Danaher), the Board of Directors of MIPS Technologies Inc. (acquired by Imagination), and currently is a member of the Board of Directors of Honeywell International, the Board of Directors of Salesforce.com, and the Board of Visitors, Graziadio School of Business and Management, Pepperdine University.
Washington has a Bachelor’s degree in Business Administration from the University of Michigan and a MBA from Pepperdine University.
